Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Integrated Proteins Ltd

INTEGFD
BSE
105.19
2.00%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Integrated Proteins Ltd

INTEGFD
BSE
105.19
2.00%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
197Cr
Close
Close Price
105.19
Industry
Industry
Trading
PE
Price To Earnings
29.63
PS
Price To Sales
7.66
Revenue
Revenue
26Cr
Rev Gr TTM
Revenue Growth TTM
10,176.00%
PAT Gr TTM
PAT Growth TTM
300.00%
Peer Comparison
How does INTEGFD stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
INTEGFD
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
0000000021040
Growth YoY
Revenue Growth YoY%
41.28,854.2-100.0
Expenses
ExpensesCr
0000000021040
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
0.0-20.8-400.01.12.1
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
300.0-200.0700.0-50.0100.0-400.0-12.5950.0266.7-128.6
NPM
NPM%
23.58.3700.01.01.2
EPS
EPS
0.1-0.10.00.20.10.0-0.10.20.62.80.2-0.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
00000000002226
Growth
Revenue Growth%
22.7-6.5-100.042.28,954.919.5
Expenses
ExpensesCr
00000000002125
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
-62.1-78.8-51.2-49.90.41.0
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth
PAT Growth%
-20.3-5.6-42.3-74.4102.6-77.5281.272.2-15.3189.0180.0-4.0
NPM
NPM%
101.4102.418.537.61.20.9
EPS
EPS
0.30.20.10.00.10.00.70.10.10.30.73.5

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
444444444443
Reserves
ReservesCr
-1-1-1-1-1-1-1-1-1-1-117
Current Liabilities
Current LiabilitiesCr
0000000000128
Non Current Liabilities
Non Current LiabilitiesCr
000000000000
Total Liabilities
Total LiabilitiesCr
33333333333229
Current Assets
Current AssetsCr
01110000003229
Non Current Assets
Non Current AssetsCr
222222333300
Total Assets
Total AssetsCr
33333333333229

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
0000000000-24
Investing Cash Flow
Investing Cash FlowCr
00000000002
Financing Cash Flow
Financing Cash FlowCr
000000000021
Net Cash Flow
Net Cash FlowCr
00000000000
Free Cash Flow
Free Cash FlowCr
0000000000-23
CFO To PAT
CFO To PAT%
-75.5-94.9-437.8-2,000.5579.0-2,790.3-435.4-253.4-389.6-66.5-9,426.0
CFO To EBITDA
CFO To EBITDA%
123.4123.3228.6288.2-102.6132.690.4119.5140.850.1-25,697.8

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
011010064613
Price To Earnings
Price To Earnings
0.08.916.00.035.00.00.0150.0133.064.855.9
Price To Sales
Price To Sales
0.09.925.924.80.6
Price To Book
Price To Book
0.00.30.30.00.40.00.02.11.72.24.9
EV To EBITDA
EV To EBITDA
7.5-4.6-3.84.8-4.01.80.3-71.8-53.4-50.1180.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.0100.012.06.42.2
OPM
OPM%
-62.1-78.8-51.2-49.90.4
NPM
NPM%
101.4102.418.537.61.2
ROCE
ROCE%
3.73.33.32.50.10.81.11.91.53.94.7
ROE
ROE%
3.73.31.90.51.00.20.91.51.23.48.8
ROA
ROA%
3.43.11.80.51.00.20.81.41.13.30.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Integrated Proteins Limited is currently undergoing a fundamental strategic transformation, pivoting from its legacy as a regional agri-processing firm into a diversified, pan-India enterprise. Under new management and control as of late **2024**, the company has ceased its traditional solvent extraction operations to focus on high-growth sectors including **Information Technology (GIS)**, **Renewable Energy**, **Infrastructure**, and **Commodity Trading**. --- ### Strategic Pivot: From Manufacturing to Multi-Sector Services The company has formally amended its **Main Object Clause** to transition from a manufacturing-centric model to a diversified service and trading provider. This shift is designed to position IPL as a "**one-stop shop**" for retailers and industrial clients. * **Information Technology & Geomatics:** IPL is entering the digital solutions space, focusing on **Geographical Information Systems (GIS)**, **Remote Sensing (RS)**, **GPS**, and **Image Processing**. Technical capabilities will include **3-D Modeling**, **Neural Networks**, **Terrain Analysis**, and **Network Analysis**. * **Infrastructure & Energy:** The company is expanding into **EPC (Engineering, Procurement, and Construction)** contracting for roads, dams, bridges, and railways. It is also targeting the **Renewable Energy** sector through the manufacturing, installation, and operation of **Solar systems**. * **Commodity Trading:** To drive immediate cash flow, the company has expanded its trading portfolio beyond traditional oilseeds (**Soybean, Mustard/Rapeseed, and Groundnut**) to include **Coal and other minerals**. * **Electrical Appliances:** New objects include manufacturing and dealing in a wide range of electrical equipment and appliances. --- ### Financial Performance & Growth Trajectory Following the shift toward trading, the company has seen a significant surge in revenue and profitability. The transition from a dormant manufacturing unit to an active trading entity is reflected in the sharp uptick in fiscal metrics. | Metric | FY 2024-25 (Projected/Reported) | FY 2023-24 (Actual) | FY 2022-23 (Actual) | | :--- | :--- | :--- | :--- | | **Revenue from Operations** | **₹21.50 Crore** | **₹23.74 Lakhs** | **₹16.67 Lakhs** | | **Other Income (Interest)** | — | **₹24.89 Lakhs** | **₹15.65 Lakhs** | | **Total Revenue** | **₹21.73 Crore** | **₹48.63 Lakhs** | **₹32.32 Lakhs** | | **Total Costs** | **₹21.41 Crore** | **₹32.32 Lakhs** | **₹28.13 Lakhs** | | **Net Profit** | **₹25.00 Lakhs** | **₹8.93 Lakhs** | **₹3.09 Lakhs** | **Key Financial Observations:** * **Profitability:** The company reported a **189% increase** in net profit between FY23 and FY24. * **Solvency:** Auditors have confirmed **no material uncertainty** regarding the company’s ability to meet its liabilities. The company has incurred **no cash losses** in the recent two-year period. * **Dividend Policy:** The Board has opted **not to recommend dividends** for **FY 2024-25**. Resources are being conserved to fund business development and to write off accumulated historical losses. --- ### Capital Restructuring & Asset Monetization To fuel its expansion into IT and Infrastructure, IPL has executed a massive capital infusion and a cleanup of its balance sheet. * **Preferential Issue:** The company approved the issuance of **2,00,00,000 Convertible Equity Warrants** to non-promoter investors at an issue price of **₹11.25** (including a **₹1.25 premium**). * **Fundraising Target:** This exercise is set to raise up to **₹22.50 Crores**. * **Authorized Capital:** To accommodate this growth, the authorized capital was increased from **₹4 Crore** to **₹25 Crore**. * **Asset Sale:** In **August 2024**, the company approved the sale of surplus land and structures in **Jamnagar, Gujarat** (approx. **36,643 Sq. Mtrs.** of land and **1,915 Sq. Mtrs.** of construction) to related parties for **₹6.50 Crores**. * **Use of Proceeds:** Funds are earmarked for **Capital Expenditure**, **Acquisitions** in new business lines, **Working Capital**, and repayment of existing borrowings. --- ### Governance & Leadership Overhaul A change in management in late **2024** has led to a complete reconstitution of the Board and a relocation of corporate operations. * **Executive Leadership:** **Mr. Karanj Dharmeshbhai Doshi** was appointed as **Managing Director** in November 2024 for a **5-year term**. * **Key Appointments:** The management team includes **Mr. Manish Natvarlal Mungra (CFO)** and **CS Urvashi Jayeshbhai Gandhi (Company Secretary)**. * **Board Composition:** The board has been strengthened with Independent Directors **Mrs. Jyoti Kataria** and **Mr. Kishan Kanjaria** to ensure compliance with **SEBI Listing Regulations**. * **Operational Relocation:** The Registered Office is shifting from **Jamnagar** to **Titanium Business Park, Ahmedabad**, reflecting the company's transition to a more centralized, scalable corporate structure. --- ### Risk Management & Compliance Profile IPL maintains a risk management framework overseen by the Audit Committee and the Board, though it acknowledges certain ongoing regulatory challenges. **Risk Categorization:** * **Strategic:** Risks related to **Technology Obsolescence** in the new IT segment and competition in the commodity trading space. * **External:** Exposure to **Regulatory changes**, **Political Risk**, and shifting legal landscapes. * **Financial:** General risks associated with long-term investments and the accuracy of financial reporting. **Current Compliance Status:** * **Director Tenure:** As of **September 2025**, the company noted a non-compliance with **Section 149(10) & (11)** of the Companies Act and **Regulation 25(2)** of SEBI (LODR). Independent Director **Bhalchandra Hiralal Vyas** remained in office beyond the maximum **10-year tenure** (which ended **March 30, 2025**). * **KMP Vacancies:** Previous vacancies in the Company Secretary role have been resolved to meet the requirements of **Section 203(4)**.